1st German Phage Symposium-Conference Report
In Germany, phage research and application can be traced back to the beginning of the 20th century. However, with the triumphal march of antibiotics around the world, the significance of bacteriophages faded in most countries, and respective research mainly focused on fundamental questions and niche applications. After a century, we pay tribute to the overuse of antibiotics that led to multidrug resistance and calls for new strategies to combat pathogenic microbes. Against this background, bacteriophages came into the spotlight of researchers and practitioners again resulting in a fast growing "phage community". In October 2017, part of this community met at the 1st German Phage Symposium to share their knowledge and experiences. The participants discussed open questions and challenges related to phage therapy and the application of phages in general. This report summarizes the presentations given, highlights the main points of the round table discussion and concludes with an outlook for the different aspects of phage application.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Viruses - 10(2018), 4 vom: 29. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Huber, Irene [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antimicrobial resistance (AMR) |
|---|
| Anmerkungen: |
Date Completed 18.09.2018 Date Revised 02.12.2018 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/v10040158 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM282473203 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM282473203 | ||
| 003 | DE-627 | ||
| 005 | 20231225034012.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/v10040158 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0941.xml |
| 035 | |a (DE-627)NLM282473203 | ||
| 035 | |a (NLM)29596346 | ||
| 035 | |a (PII)E158 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Huber, Irene |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 1st German Phage Symposium-Conference Report |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.09.2018 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In Germany, phage research and application can be traced back to the beginning of the 20th century. However, with the triumphal march of antibiotics around the world, the significance of bacteriophages faded in most countries, and respective research mainly focused on fundamental questions and niche applications. After a century, we pay tribute to the overuse of antibiotics that led to multidrug resistance and calls for new strategies to combat pathogenic microbes. Against this background, bacteriophages came into the spotlight of researchers and practitioners again resulting in a fast growing "phage community". In October 2017, part of this community met at the 1st German Phage Symposium to share their knowledge and experiences. The participants discussed open questions and challenges related to phage therapy and the application of phages in general. This report summarizes the presentations given, highlights the main points of the round table discussion and concludes with an outlook for the different aspects of phage application | ||
| 650 | 4 | |a Congress | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Germany | |
| 650 | 4 | |a antimicrobial resistance (AMR) | |
| 650 | 4 | |a bacteriophage | |
| 650 | 4 | |a co-evolution | |
| 650 | 4 | |a horizontal gene transfer | |
| 650 | 4 | |a industrial phage application | |
| 650 | 4 | |a phage | |
| 650 | 4 | |a phage therapy | |
| 700 | 1 | |a Potapova, Katerina |e verfasserin |4 aut | |
| 700 | 1 | |a Kuhn, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Schmidt, Herbert |e verfasserin |4 aut | |
| 700 | 1 | |a Hinrichs, Jörg |e verfasserin |4 aut | |
| 700 | 1 | |a Rohde, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Beyer, Wolfgang |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Viruses |d 2009 |g 10(2018), 4 vom: 29. März |w (DE-627)NLM192382764 |x 1999-4915 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2018 |g number:4 |g day:29 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/v10040158 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2018 |e 4 |b 29 |c 03 | ||